HIV-1 combined pheno- and genotyping provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). Useful in clarifying and confirming results from HIV genotyping tests. Intended for patients with viral load >500 copies/mL.
Lavender (EDTA) or Plasma Preparation Tube (PPT).
Separate from cells within 6 hours of collection. Transfer 3 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 1 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Provide patient's most recent viral load and viral load collection date.
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks
No compliance statements are in use for this test.
Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
87900; 87901; 87903; 87904 x11
|Component Test Code*||Component Chart Name||LOINC|
|0092074||Viral Load Date||19151-0|
|2003232||EER HIV PhenoSense GT||11526-1|
- HIV Resistance